ArticleFrontiers in immunology2018

Ranitidine Inhibition of Breast Tumor Growth Is B Cell Dependent and Associated With an Enhanced Antitumor Antibody Response.

Dakota Rogers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.